AtriCure EBIT Margin 2010-2025 | ATRC
Current and historical EBIT (Earnings Before Interest & Taxes) margin for AtriCure (ATRC) over the last 10 years. The current EBIT profit margin for AtriCure as of June 30, 2025 is .
| AtriCure EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2025-06-30 | $0.50B | $-0.03B | -6.80% |
| 2025-03-31 | $0.48B | $-0.04B | -7.29% |
| 2024-12-31 | $0.47B | $-0.04B | -8.60% |
| 2024-09-30 | $0.45B | $-0.03B | -7.59% |
| 2024-06-30 | $0.43B | $-0.04B | -8.14% |
| 2024-03-31 | $0.42B | $-0.03B | -7.71% |
| 2023-12-31 | $0.40B | $-0.03B | -6.77% |
| 2023-09-30 | $0.38B | $-0.02B | -5.79% |
| 2023-06-30 | $0.37B | $-0.03B | -6.85% |
| 2023-03-31 | $0.35B | $-0.04B | -10.03% |
| 2022-12-31 | $0.33B | $-0.04B | -12.99% |
| 2022-09-30 | $0.32B | $-0.05B | -16.46% |
| 2022-06-30 | $0.30B | $0.06B | 19.14% |
| 2022-03-31 | $0.29B | $0.06B | 19.72% |
| 2021-12-31 | $0.27B | $0.06B | 20.15% |
| 2021-09-30 | $0.26B | $0.05B | 19.38% |
| 2021-06-30 | $0.24B | $-0.05B | -21.81% |
| 2021-03-31 | $0.21B | $-0.05B | -21.13% |
| 2020-12-31 | $0.21B | $-0.04B | -21.26% |
| 2020-09-30 | $0.21B | $-0.04B | -19.52% |
| 2020-06-30 | $0.21B | $-0.05B | -21.70% |
| 2020-03-31 | $0.23B | $-0.04B | -18.70% |
| 2019-12-31 | $0.23B | $-0.03B | -14.29% |
| 2019-09-30 | $0.22B | $-0.02B | -9.42% |
| 2019-06-30 | $0.22B | $-0.02B | -8.33% |
| 2019-03-31 | $0.21B | $-0.01B | -6.22% |
| 2018-12-31 | $0.20B | $-0.02B | -8.42% |
| 2018-09-30 | $0.20B | $-0.02B | -8.21% |
| 2018-06-30 | $0.19B | $-0.02B | -9.09% |
| 2018-03-31 | $0.18B | $-0.02B | -13.33% |
| 2017-12-31 | $0.17B | $-0.03B | -14.37% |
| 2017-09-30 | $0.17B | $-0.03B | -18.34% |
| 2017-06-30 | $0.17B | $-0.03B | -18.18% |
| 2017-03-31 | $0.16B | $-0.03B | -20.00% |
| 2016-12-31 | $0.16B | $-0.03B | -20.00% |
| 2016-09-30 | $0.15B | $-0.03B | -22.67% |
| 2016-06-30 | $0.14B | $-0.03B | -23.78% |
| 2016-03-31 | $0.14B | $-0.03B | -22.79% |
| 2015-12-31 | $0.13B | $-0.03B | -20.77% |
| 2015-09-30 | $0.12B | $-0.02B | -17.07% |
| 2015-06-30 | $0.12B | $-0.02B | -13.45% |
| 2015-03-31 | $0.11B | $-0.01B | -12.39% |
| 2014-12-31 | $0.11B | $-0.02B | -15.74% |
| 2014-09-30 | $0.10B | $-0.02B | -16.83% |
| 2014-06-30 | $0.09B | $-0.02B | -20.21% |
| 2014-03-31 | $0.09B | $-0.02B | -20.69% |
| 2013-12-31 | $0.08B | $-0.01B | -14.81% |
| 2013-09-30 | $0.08B | $-0.01B | -11.69% |
| 2013-06-30 | $0.07B | $-0.01B | -12.33% |
| 2013-03-31 | $0.07B | $-0.01B | -11.27% |
| 2012-12-31 | $0.07B | $-0.01B | -10.14% |
| 2012-09-30 | $0.07B | $-0.01B | -10.29% |
| 2012-06-30 | $0.07B | $-0.01B | -7.46% |
| 2012-03-31 | $0.07B | $-0.01B | -7.58% |
| 2011-12-31 | $0.07B | $-0.01B | -7.69% |
| 2011-09-30 | $0.06B | $0.00B | -4.69% |
| 2011-06-30 | $0.06B | $0.00B | -4.76% |
| 2011-03-31 | $0.06B | $0.00B | -3.33% |
| 2010-12-31 | $0.06B | $0.00B | -5.17% |
| 2010-09-30 | $0.06B | $-0.01B | -8.93% |
| 2010-06-30 | $0.06B | $-0.01B | -14.55% |
| 2010-03-31 | $0.06B | $-0.01B | -16.36% |
| 2009-12-31 | $0.06B | $-0.02B | -27.27% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.881B | $0.465B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.514B | 26.91 |
| Boston Scientific (BSX) | United States | $155.747B | 37.14 |
| Stryker (SYK) | United States | $149.436B | 30.42 |
| EssilorLuxottica (ESLOY) | France | $144.168B | 0.00 |
| Medtronic (MDT) | Ireland | $117.977B | 16.64 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.715B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.412B | 24.82 |
| ResMed (RMD) | United States | $41.845B | 29.93 |
| GE HealthCare Technologies (GEHC) | United States | $34.055B | 16.01 |
| Agilent Technologies (A) | United States | $33.846B | 22.07 |
| Koninklijke Philips (PHG) | Netherlands | $26.577B | 17.58 |
| Terumo (TRUMY) | Japan | $26.206B | 31.05 |
| Insulet (PODD) | United States | $23.159B | 77.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.260B | 13.53 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.271B | 0.00 |
| Baxter (BAX) | United States | $12.615B | 9.75 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.048B | 29.56 |
| Lantheus Holdings (LNTH) | United States | $3.819B | 10.32 |
| Envista Holdings (NVST) | United States | $3.510B | 24.56 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.272B | 8.17 |
| Prestige Consumer Healthcare (PBH) | United States | $3.231B | 14.34 |
| ICU Medical (ICUI) | United States | $3.106B | 21.15 |
| Haemonetics (HAE) | United States | $2.661B | 11.88 |
| LeMaitre Vascular (LMAT) | United States | $2.209B | 47.38 |
| Acuren (TIC) | United States | $2.126B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.005B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.877B | 11.82 |
| Green Thumb Industries (GTBIF) | United States | $1.869B | 80.25 |
| Tilray Brands (TLRY) | Canada | $1.530B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.295B | 16.55 |
| AdaptHealth (AHCO) | United States | $1.249B | 17.75 |
| BioLife Solutions (BLFS) | United States | $1.229B | 2565.00 |
| Neogen (NEOG) | United States | $1.216B | 19.31 |
| InMode (INMD) | Israel | $0.921B | 8.52 |
| Kestra Medical Technologies (KMTS) | United States | $0.910B | 0.00 |
| Valneva SE (VALN) | France | $0.802B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.648B | 0.00 |
| SNDL (SNDL) | Canada | $0.631B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.613B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.593B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.61 |
| Surmodics (SRDX) | United States | $0.505B | 0.00 |
| Evolus (EOLS) | United States | $0.481B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.473B | 16.29 |
| CeriBell (CBLL) | United States | $0.419B | 0.00 |
| Owens & Minor (OMI) | United States | $0.396B | 3.51 |
| Sanuwave Health (SNWV) | United States | $0.366B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.345B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.331B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.302B | 0.00 |
| Omeros (OMER) | United States | $0.296B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.295B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| Brainsway (BWAY) | Israel | $0.290B | 59.08 |
| High Tide (HITI) | Canada | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 20.85 |
| TriSalus Life Sciences (TLSI) | United States | $0.246B | 0.00 |
| Cerus (CERS) | United States | $0.245B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.243B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| Organigram Global (OGI) | Canada | $0.219B | 0.00 |
| Quanterix (QTRX) | United States | $0.217B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.193B | 16.13 |
| FitLife Brands (FTLF) | United States | $0.171B | 21.05 |
| Biote (BTMD) | United States | $0.160B | 5.30 |
| Jushi Holdings (JUSHF) | United States | $0.142B | 0.00 |
| Jin Medical (ZJYL) | China | $0.133B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.113B | 0.00 |
| MacroGenics (MGNX) | United States | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 12.31 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.078B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.066B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 32.03 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.051B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 34.92 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.36 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Sharps Technology (STSS) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |